April 7, 1:00 p.m.
Fireside Chat with Max Wallace and Don Lo
April 7th ; 1:00 PM
Okey Patteson Auditorium
Max Wallace and Don Lo are joining us on April 7th for a free ranging Fireside Chat about their experiences launching successful life science companies from academic institutions, work they have done in commercializing breakthrough discoveries, and research and their views on the role academia plays in bringing cutting edge treatments to patients.
Max is CEO of Accelerate Brain Cancer Cure, and was previously: CEO of TheraLogics (cancer therapeutics), Founder and President of Trimeris (HIV Therapeutics), Founder Cogent Neuroscience, Sphinx Pharmaceuticals, and SARCO. He is an active board member of tissue engineering company, Humacyte – Fast company referenced them as one of the 10 most innovative biotech companies in the US and they recently completed a $150 Million financing.
Don is Director of the Center for Drug Discovery at Duke University and Associate Professor of Neurobiology at Duke Medical Center. He has been engaged in basic science and drug discovery research for neurological diseases for over 25 years. Don was Co-founder and Chief Science Officer of Cogent Neuroscience until 2002 when he returned to Duke to establish Duke’s Center for Drug Discovery.
Come celebrate with the WVU community and special guests on April 7, 4:30 p.m. at the Blanchette Rockefeller Neurosciences Institute as we open the doors to WVU’s new “Health Sciences Innovation Center.”
This is the new home of our life sciences technology transfer team, and includes incubation wet labs for WVU's growing roster of life sciences startups. Tour the labs and meet some of the life sciences startups that are beginning to be incubated at the Health Sciences Innovation Center.
For more information, please contact:
Director Health Sciences Innovation, Entrepreneurship, and Commercialization
2268 Health Sciences South
Patrick Ma, M.D., co-leader of the WVU Cancer Institute Sara Crile Allen & James Frederick Allen Comprehensive Lung Cancer Program and director of the Clinical Lung Cancer Program, and Xiaoliang Wu, M.D., Ph.D., postdoctoral research fellow in Dr. Ma’s lab, were featured presenters at the 2018 American Society of Clinical Oncology (ASCO) Annual Scientific Meeting this June.
The National Institutes of Health (NIH) Common Fund announces fiscal year 2019 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program.
West Virginia University researchers may have uncovered the cause of muscle fatigue in breast cancer patients.